Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma. BMC Cancer.
Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma. BMC Cancer.
复制标题
经导管动脉化疗栓塞联合射频消融可延缓肿瘤进展并延长中期（BCLC B）肝细胞癌患者的总生存期。
作者：
Ge NL;Chen Y;Li LX;Ren ZG
